NCT06521866 2025-03-14
Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer
Fudan University
Phase 2 Recruiting
Fudan University
Binhui Biopharmaceutical Co., Ltd.
Peking University Cancer Hospital & Institute
Fudan University